Intensive and Perioperative Care. Skåne University Hospital. Lund
Lund, Skåne County, 22185, Sweden
NCT Number: NCT05513378
OBJECTIVES The primary objective is to compare if the addition of a needle guide can reduce the number of central venous catheter (CVC) insertions with >1 skin puncture in ultrasound-guided catheterization of the subclavian vein using the long-axis approach with an in-plane needling technique.
Secondary objectives include if this addition 1) decreases the frequency of mechanical complications (defined as bleeding, arterial puncture, arterial catheterization, nerve injury, pneumothorax), 2) increases the time when the needle is visible, 3) decreases the time until successful vessel punction, 4) decreases the number of needle redirections during the insertion, and 5) a comparison between the two groups regarding number of failed catheterizations.
DESIGN This is a prospective, randomised, controlled, parallel intervention study. Patients will be enrolled at Skåne University Hospital in Lund, Sweden. The trial is investigator-initiated and non-commercial.
POPULATION AND INTERVENTION Adults (18 years of age or older) in need of a subclavian CVC for any reason and able to give written informed consent will be included in the study provided no exclusion criteria is fulfilled.
OUTCOMES Primary outcome will be number of CVC insertions with >1 skin puncture. Secondary outcomes include comparison between the two groups regarding 1) the frequency of mechanical complications, 2) proportion of the insertion-time when the needle is visible on the ultrasound (US) screen, 3) time to successful vessel punction, 4) the number of needle redirections during the insertion, 5) number of failed catheterisations, 6) Feasibility of the needle guide evaluated with a questionair to the operators at the end of the study.
Looking for future studies?
Notify Me18 year–105 year
All sexes
Interventional
Not applicable
Lund, Skåne County, 22185, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Please see the arm/group description
Other names: The Ultra-Pro II™ Needle Guide, model C8-5 Philips
Time frame: During the central venous catheterization, up to 3 hours after inclusion
Number of subclavian catheter insertions with >1 skin puncture
Time frame: 24 hours after the completion of the central venous catheterization
Mechanical complication include: 1) Bleeding World Health Organization (WHO)-grade 2-4. 2) Pneumothorax visible on post-procedural Xray. 3) Permanent nerve injury. 4) Arrhythmia WHO-grade 3 and 4. 5) Arterial catheterization
Time frame: During the central venous catheterization, up to 4 hours after inclusion
Proportion of the insertion-time when the needle is visible on the ultrasound screen
Time frame: During the central venous catheterization, up to 4 hours after inclusion
Time to successful vessel puncture
Time frame: During the central venous catheterization, up to 4 hours after inclusion
The number of needle redirections during the insertion
Time frame: During the central venous catheterization, up to 4 hours after inclusion
The number of failed catheterizations in the attempted subclavian vein
Time frame: Through the study period, anticipated 3 years
Feasibility of the needle guide by means of a questionnaire at the end of the study period.
Thomas Kander
Other
A Randomized Controlled Trial Comparing In-line Ultrasound Guided Subclavian Vein Catheterization With or Without Needle Guide.
Acronym: ELUSIVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07459088
Catheterization, Central Venous
Tunis, Tunisia
View Trial DetailsNCT04274881
Anatomic Landmarks, Catheterization, Central Venous
Cairo, Egypt
View Trial DetailsNCT05387486
Catheterization, Central Venous
Karachi, Sindh, Pakistan
View Trial DetailsNCT03530618
Catheterization, Central Venous
Seoul, South Korea
View Trial Details